期刊文献+

胰高血糖素样肽-2与肠道损伤的关系及相关机制的研究进展

Research progress in the relationship between glucagon-like peptide-2 and intestinal injury and related mechanisms
原文传递
导出
摘要 胰高血糖素样肽-2(GLP-2)是一种具有肠道保护作用的特异性生长因子, 通过多种下游信号通路发挥对肠道损伤后的再生修复作用, 主要体现在保证肠道结构的完整性, 增强肠道屏障的功能, 增加肠道的血液供应, 以及促进营养物质的吸收。因此, 其在肠道损伤的临床应用中也越来越普遍。本文将概括总结GLP-2的特性、与肠道损伤的关系、作用机制和临床应用等方面的最新研究进展。 Glucagon-like peptide-2(GLP-2)is a specific growth factor with intestinal protective effect.It plays a role in the regeneration and repair of intestinal injury through a variety of downstream signal pathways,which is mainly reflected in ensuring the integrity of intestinal structure,enhancing the function of intestinal barrier,increasing the blood supply of intestinal tract,and promoting the absorption of nutrients.Therefore,it is more and more popular in the clinical application of intestinal injury.This paper will summarize the latest research progress in the characteristics of GLP-2,its relationship with intestinal injury,mechanism of action and clinical application.
作者 赵挺威 张丰 Zhao Tingwei;Zhang Feng(Department of Gastrointestinal Surgery,Changzhou First People′s Hospital,Changzhou 213004,China)
出处 《国际外科学杂志》 2023年第9期631-635,共5页 International Journal of Surgery
关键词 胰高血糖素样肽2 肠道营养 治疗应用 Glucagon-like peptide-2 Enteral nutrition Therapeutic uses
  • 相关文献

参考文献7

二级参考文献81

  • 1蒋义,贾刚,惠明弟,陈小玲,李华,王康宁.胰高血糖素样肽-2对断奶仔猪肠上皮紧密连接蛋白相关基因表达的影响[J].动物营养学报,2012,24(9):1785-1792. 被引量:14
  • 2关莉莉,宫德正,田楠,邹原.胰高血糖素样肽-2对小鼠小肠缺血/再灌注损伤的保护作用[J].中国应用生理学杂志,2005,21(2):192-195. 被引量:7
  • 3谭虎,杨天德,粟永萍,艾国平,黄岚,陶军,刘晓宏,楼淑芬.修饰GLP2分泌性表达载体的构建及促增殖活性测定的实验研究[J].第三军医大学学报,2007,29(17):1650-1653. 被引量:3
  • 4Benjamin M A,McKay D M,Yang P C,et al.Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both transcellular and paracellular pathways in the mouseGut,2000.
  • 5Mazzon E,Sturniolo GC,Puzzolo D,et al.Effect of stress on the paracellular barrier in the rat ileumGut,2002.
  • 6Cameron Heather L,Perdue Mary H.Stress impairs murine intestinal barrier function: improvement by glucagon-like peptide-2. The Journal of pharmacology and experimental therapeutics . 2005
  • 7Erzsebet Paszti-Gere,Gabor Matis,Orsolya Farkas,Anna Kulcsar,Orsolya Palocz,Gyorgy Csiko,Zsuzsanna Neogrady,Peter Galfi.The Effects of Intestinal LPS Exposure on Inflammatory Responses in a Porcine Enterohepatic Co-culture System[J]. Inflammation . 2014 (1)
  • 8David L. Sigalet,Elaine de Heuvel,Laurie Wallace,Estrella Bulloch,Justine Turner,Patrick Nation,Pamela R. Wizzard,Bollette Hartmann,Meena Assad,Jens J. Holst.Effects of chronic glucagon-like peptide-2 therapy during weaning in neonatal pigs[J]. Regulatory Peptides . 2013
  • 9R.M. Naimi,K.B. Madsen,C. Askov-Hansen,C.F. Brandt,B. Hartmann,J.J. Holst,P.B. Mortensen,P.B. Jeppesen.A dose-equivalent comparison of the effects of continuous subcutaneous glucagon-like peptide 2 (GLP-2) infusions versus meal related GLP-2 injections in the treatment of short bowel syndrome (SBS) patients[J]. Regulatory Peptides . 2013
  • 10Yongqing Hou,Lei Wang,Wei Zhang,Zhenguo Yang,Binying Ding,Huiling Zhu,Yulan Liu,Yinsheng Qiu,Yulong Yin,Guoyao Wu.Protective effects of N-acetylcysteine on intestinal functions of piglets challenged with lipopolysaccharide[J]. Amino Acids . 2012 (3)

共引文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部